INDIA-BANGLADESH SECRETARY LEVEL
TRADE TALKS HELD
India-Bangladesh
Commerce Secretary level talks were held in New Delhi on 24th
and 25th March, 2003 preceded by Joint Secretary level
talks on 23rd March, 2003. These talks were held in
a very warm and cordial atmosphere reflecting the close bilateral
relation between the two countries. The two delegations were led
by Shri Dipak Chatterjee, Secretary, Department of Commerce, Government
of India and Mr. Suhel Ahmed Chowdhury, Secretary Ministry of
Commerce, Government of the Republic of Bangladesh, respectively.
The Bangladesh delegation
also called on Shri Arun Jaitley, Minister of Commerce & Industry
and Law & Justice, Government of India, on 25th
March, 2003.
India pointed out
the enormous delay in convening a meeting of the Joint Group of
Experts (JGE) of the two countries to consider issues relating
to Border Trade, Trans-shipment of Indian goods through Bangladesh
territory and deepening of tariff concessions. Bangladesh responded
that these issues would be discussed in the upcoming Joint Economic
Commission Meeting in July, 2003 in Dhaka.
The Indian side announced
its willingness to grant duty free access to Bangladesh products
on 39 tariff lines. This includes 11 out of 121 tariff lines from
a request list of 2002 and 28 out of 191 tariff lines from an
earlier request list from Bangladesh. India also announced that
further duty free concessions could be considered under the framework
of a bilateral Free Trade Arrangement. Bangladesh agreed to initiate
discussion on a Free Trade Arrangement.
India and Bangladesh
also set up a Joint Working Group headed by two Joint Secretaries
of their respective Commerce Ministries to look into complaints
of Non-tariff and Para-tariff barriers from either side and take
steps to address them.
India and Bangladesh
agreed on a common list of Land Customs Stations on the India-Bangladesh
border and agreed on a time schedule to improve their infrastructure
facilities.
India and Bangladesh
further announced that they would be concluding a Bilateral Protection
and Promotion Agreement (BIPPA) in the near future. India pointed
out that the inordinate delay in granting the drug manufacturing
licence to a joint venture in Bangladesh promoted by Sun Pharma
of India was having an adverse impact on the flow of Indian investments
into Bangladesh.